176 related articles for article (PubMed ID: 29549189)
21. Investigation of grey matter abnormalities in multiple sclerosis patients by combined use of double inversion recovery sequences and diffusion tensor MRI at 3.0 Tesla.
Han X; Wang X; Wang L; Zheng Z; Gu J; Tang D; Liu L; Liu S
Clin Radiol; 2018 Sep; 73(9):834.e17-834.e23. PubMed ID: 29861163
[TBL] [Abstract][Full Text] [Related]
22. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of 2-year "No evidence of disease activity" (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis. A real-world study.
Bazzurri V; Fiore A; Curti E; Tsantes E; Franceschini A; Granella F
Mult Scler Relat Disord; 2023 Nov; 79():105015. PubMed ID: 37769430
[TBL] [Abstract][Full Text] [Related]
24. No evidence of disease activity-3 (NEDA-3) status in patients with relapsing remitting multiple sclerosis: Evidence from Saudi cohort receiving mainly Interferon.
Zafar A; AlShamrani FJG
Mult Scler Relat Disord; 2021 Jun; 51():102875. PubMed ID: 33691260
[TBL] [Abstract][Full Text] [Related]
25. Hemispheric asymmetry measured by texture analysis and diffusion tensor imaging in two multiple sclerosis subtypes.
Savio S; Hakulinen U; Ryymin P; Hagman S; Dastidar P; Soimakallio S; Elovaara I; Eskola H
Acta Radiol; 2015 Jul; 56(7):844-51. PubMed ID: 25024438
[TBL] [Abstract][Full Text] [Related]
26. Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.
Chiang GC; Pinto S; Comunale JP; Gauthier SA
J Neuroimaging; 2016 May; 26(3):289-95. PubMed ID: 26458494
[TBL] [Abstract][Full Text] [Related]
27. Brain volume loss and no evidence of disease activity over 3 years in multiple sclerosis patients under interferon beta 1a subcutaneous treatment.
Rojas JI; Sanchez F; Caro F; Miguez J; Patrucco L; Funes J; Cristiano E
J Clin Neurosci; 2019 Jan; 59():175-178. PubMed ID: 30401571
[TBL] [Abstract][Full Text] [Related]
28. Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter.
Cassol E; Ranjeva JP; Ibarrola D; Mékies C; Manelfe C; Clanet M; Berry I
Mult Scler; 2004 Apr; 10(2):188-96. PubMed ID: 15124766
[TBL] [Abstract][Full Text] [Related]
29. Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
Uher T; Havrdova E; Sobisek L; Krasensky J; Vaneckova M; Seidl Z; Tyblova M; Ramasamy D; Zivadinov R; Horakova D
Mult Scler; 2017 Feb; 23(2):242-252. PubMed ID: 27230790
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis.
Prosperini L; Ruggieri S; Haggiag S; Tortorella C; Pozzilli C; Gasperini C
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34373345
[TBL] [Abstract][Full Text] [Related]
31. Early MRI results and odds of attaining 'no evidence of disease activity' status in MS patients treated with interferon β-1a in the EVIDENCE study.
Coyle PK; Reder AT; Freedman MS; Fang J; Dangond F
J Neurol Sci; 2017 Aug; 379():151-156. PubMed ID: 28716230
[TBL] [Abstract][Full Text] [Related]
32. Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies.
Havrdova E; Giovannoni G; Gold R; Fox RJ; Kappos L; Phillips JT; Okwuokenye M; Marantz JL
Eur J Neurol; 2017 May; 24(5):726-733. PubMed ID: 28328179
[TBL] [Abstract][Full Text] [Related]
33. No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
Damasceno A; Damasceno BP; Cendes F
Mult Scler; 2016 Jan; 22(1):64-72. PubMed ID: 26432855
[TBL] [Abstract][Full Text] [Related]
34. Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration.
Deppe M; Tabelow K; Krämer J; Tenberge JG; Schiffler P; Bittner S; Schwindt W; Zipp F; Wiendl H; Meuth SG
Mult Scler; 2016 Jan; 22(1):73-84. PubMed ID: 25921041
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging.
Rashid W; Hadjiprocopis A; Davies G; Griffin C; Chard D; Tiberio M; Altmann D; Wheeler-Kingshott C; Tozer D; Thompson A; Miller DH
J Neurol; 2008 Mar; 255(3):390-7. PubMed ID: 18350361
[TBL] [Abstract][Full Text] [Related]
36. Diffusion tensor imaging findings in the multiple sclerosis patients and their relationships to various aspects of disability.
Pokryszko-Dragan A; Banaszek A; Nowakowska-Kotas M; Jeżowska-Jurczyk K; Dziadkowiak E; Gruszka E; Zagrajek M; Bilińska M; Budrewicz S; Sąsiadek M; Bladowska J
J Neurol Sci; 2018 Aug; 391():127-133. PubMed ID: 30103962
[TBL] [Abstract][Full Text] [Related]
37. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
[TBL] [Abstract][Full Text] [Related]
38. Differences in Gaussian diffusion tensor imaging and non-Gaussian diffusion kurtosis imaging model-based estimates of diffusion tensor invariants in the human brain.
Lanzafame S; Giannelli M; Garaci F; Floris R; Duggento A; Guerrisi M; Toschi N
Med Phys; 2016 May; 43(5):2464. PubMed ID: 27147357
[TBL] [Abstract][Full Text] [Related]
39. Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis.
Tsantes E; Curti E; Collura F; Bazzurri V; Fiore A; Granella F
J Neurol Sci; 2020 Jul; 414():116827. PubMed ID: 32289575
[TBL] [Abstract][Full Text] [Related]
40. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study.
Calabrese M; Rinaldi F; Seppi D; Favaretto A; Squarcina L; Mattisi I; Perini P; Bertoldo A; Gallo P
Radiology; 2011 Dec; 261(3):891-8. PubMed ID: 22031708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
